Delivery Order SPE2DB22D3004-SPE2DB23FQA84
Award Date
5/4/23
Potential Completion Date
5/5/23
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,851.79 firm fixed-price delivery order is for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, with an ID of SPE2DB25D3002|SPE2DB25FLPRB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,436.67 Firm Fixed Price Delivery Order contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award, SPE2DB20D1100|SPE2DB25FZ43V, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The $1,707.24 firm fixed-price delivery order is for the pharmaceutical product TROKENDI XR 100 MG CAPSULE 30S, with a completion date of December 9, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,436.67 firm fixed-price delivery order is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB25FT7E4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,965.33, is a delivery order for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 3, 2025. It is not designated under any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,345.33 firm fixed-price delivery order is for the supply of 4564530304 - TROKENDI XR 50 MG CAPSULE 30S, a specialty medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $2,019.15 and is a Firm Fixed Price Delivery Order for the product "TROKENDI XR 200 MG CAPSULE 30S". The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, identified as SPE2DB20D2104/SPE2DB23FS09Q, is a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,788.99 and covers the delivery of 4559862500 TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,240.88 Firm Fixed Price Delivery Order is for the supply of Trokendi XR 200 mg capsules, a specialty medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,267.25 firm-fixed-price delivery order is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of August 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...